r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

DH

David P. Hochman

Insider · Director and Officer · OBIO

David P. Hochman files insider transactions with the SEC as a director and officer of Orchestra BioMed Holdings (OBIO). We hold 4 disclosed purchases and sales filed since 9 March 2006, 1 of them in the last 90 days.

  • Files forOBIO
  • Disclosed buys and sells4 in all, 1 in the last 90 days
  • Last disclosure8 September 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 26 January 2023 — 3 September 2026Director and Officer · Orchestra BioMed Holdings (OBIO)70 Form 4 lines · source: SEC Form 4
  • Filed 16 February 2018 — 10 February 2022DirectorOther · Motus GI Holdings (MOTS)33 Form 4 lines · source: SEC Form 4
  • Filed 25 November 2014 — 20 May 2020Director · Corbus Pharmaceuticals Holdings (CRBP)31 Form 4 lines · source: SEC Form 4
  • Filed 10 June 2014 — 13 March 2017Director and 10% owner · Naked Brand Group (NAKD)28 Form 4 lines · source: SEC Form 4
  • Filed 5 June 2006 — 30 March 2007Director · Orchestra Therapeutics (OCHT)2 Form 4 lines · source: SEC Form 4
  • Filed 7 March 2006 — 21 August 2006Director · Immune Response (IMNR)9 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.